An Association for Accessible Medicines (AAM) report has found that Medicare Part D Plans continue to underperform in providing access to new Generic Drugs to patients, compared to commercial plans. Generic drugs and biosimilars are saving the US healthcare system millions of dollars but the new report has raised concerns.

The post Medicare Part D Plan Underperforms In Providing New Generic Drugs to Patients, Says AAM appeared first on Latest Health & Medical News – Myhealthyclick.com.